Participate In Research

Liver Cancer3 Results found

Study of Tivantinib in Subjects With Inoperable Hepatocellular Carcinoma Who Have Been Treated With One Prior Therapy (METIV-HCC)

The purpose of this study is to determine if tivantinib (ARQ 197) is effective in treating patients with MET diagnostic-high hepatocellular carcinoma (liver cancer) who have already been treated once with another therapy.

Principal Investigator

Alan Weiss

Body Locations and Systems

Cancer, Hepatitis C

Area

Vancouver

Age

18 and above

Efficacy Evaluation of TheraSphere in Patients With Inoperable Liver Cancer (STOP-HCC)

The safety and effectiveness of TheraSphere will be evaluated in patients with unresectable hepatocellular carcinoma in whom treatment with standard-of-care sorafenib is planned. All patients receive the standard-of-care sorafenib with or without the addition of TheraSphere.

Principal Investigator

David Ming-Teh Liu

Body Locations and Systems

Liver

Area

Vancouver

Age

18 and above

Study of Pembrolizumab (MK-3475) as Monotherapy in Adults With Previously Systemically Treated Advanced Hepatocellular Carcinoma (MK-3475-224/KEYNOTE-224)

This is a efficacy and safety study of pembrolizumab (MK-3475, KEYTRUDA®) as monotherapy in participants with previously systemically treated hepatocellular carcinoma (HCC).

Principal Investigator

Eric M. Yoshida

Body Locations and Systems

Cancer

Area

Vancouver

Age

18 and above

VCH Research Institute

Body Systems

Arteries (12)

Blood (25)

Heart (47)

Veins (1)

Bones (7)

Hip, Leg and Foot (8)

Joints (13)

Muscles (1)

Shoulder, Arm and Hand (1)

Spine (4)

Brain (88)

Spinal Cord (5)

Large Intestine (11)

Liver (28)

Small Intestine (10)

Ear (1)

Nose (1)

Throat (1)

Pancreas (18)

Thyroid (1)

Eye Disorders (15)

HIV (1)

Immune System and Disorders (6)

Bladder (4)

Kidney (22)

Lungs (28)

Men's Health (24)

Women's Health (26)

Mouth (1)

Skin Conditions (19)

Disorders and Conditions

Diagnosis and Therapy

Liver Cancer3 Results found

Study of Tivantinib in Subjects With Inoperable Hepatocellular Carcinoma Who Have Been Treated With One Prior Therapy (METIV-HCC)

Efficacy Evaluation of TheraSphere in Patients With Inoperable Liver Cancer (STOP-HCC)

Study of Pembrolizumab (MK-3475) as Monotherapy in Adults With Previously Systemically Treated Advanced Hepatocellular Carcinoma (MK-3475-224/KEYNOTE-224)

Body Systems

Arteries (12)

Blood (25)

Heart (47)

Veins (1)

Bones (7)

Hip, Leg and Foot (8)

Joints (13)

Muscles (1)

Shoulder, Arm and Hand (1)

Spine (4)

Brain (88)

Spinal Cord (5)

Large Intestine (11)

Liver (28)

Small Intestine (10)

Ear (1)

Nose (1)

Throat (1)

Pancreas (18)

Thyroid (1)

Eye Disorders (15)

HIV (1)

Immune System and Disorders (6)

Bladder (4)

Kidney (22)

Lungs (28)

Men's Health (24)

Women's Health (26)

Mouth (1)

Skin Conditions (19)

Disorders and Conditions

Diagnosis and Therapy

Liver Cancer3 Results found

Study of Tivantinib in Subjects With Inoperable Hepatocellular Carcinoma Who Have Been Treated With One Prior Therapy (METIV-HCC)

Efficacy Evaluation of TheraSphere in Patients With Inoperable Liver Cancer (STOP-HCC)

Study of Pembrolizumab (MK-3475) as Monotherapy in Adults With Previously Systemically Treated Advanced Hepatocellular Carcinoma (MK-3475-224/KEYNOTE-224)

Subscribe to our mailing list